Ionis Pharmaceuticals Inc. | Key People and Executives
Stanley T. Crooke
Chairman, President & Chief Executive Officer
B. Lynne Parshall
Director
Joseph Loscalzo
Independent Outside Director
Breaux B. Castleman
Independent Outside Director
Spencer R. Berthelsen
Independent Outside Director
Joseph R. Klein
Independent Outside Director
Frederick T. Muto
Independent Outside Director
Joseph H. Wender
Independent Outside Director
Stanley T. Crooke
Chairman, President & Chief Executive Officer
Brett P. Monia
Chief Operating Officer
Elizabeth L. Hougen
CFO, Principal Accounting Officer & SVP-Finance
Sanjay Bhanot
Chief Medical Officer
C. Frank Bennett
Senior Vice President-Antisense Research
Damien McDevitt
Chief Business Officer
Patrick R. O'Neil
Secretary, Chief Compliance Officer & SVP-Legal
Eugene Schneider
Vice President-Clinical Development
Richard S. Geary
Senior Vice President-Development
Sarah Boyce
Chief Business Officer
B. Lynne Parshall
Director
D. Wade Walke
VP-Corporate Communications & Investor Relations
Joseph Loscalzo
Independent Outside Director
Breaux B. Castleman
Independent Outside Director
Spencer R. Berthelsen
Independent Outside Director
Joseph R. Klein
Independent Outside Director
Frederick T. Muto
Independent Outside Director
Joseph H. Wender
Independent Outside Director
| Address |
2855 Gazelle Court
Carlsbad California 92010
United States
|
|
Employees
|
- |
| Website |
http://www.ionispharm.com |
| Updated |
07/08/2019 |
| Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core and Akcea Therapeutics segments. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. |
